Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Treatment of neuromyelitis optica with rituximab: a 2-year prospective multicenter study.

Cabre P, Mejdoubi M, Jeannin S, Merle H, Plumelle Y, Cavillon G, Smadja D, Marignier R; Francophone Society of Multiple Sclerosis and OFSEP investigators.

J Neurol. 2018 Apr;265(4):917-925. doi: 10.1007/s00415-018-8771-5. Epub 2018 Feb 17.

PMID:
29455361
2.

Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis.

Viaccoz A, Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V, Antoine JC, Delattre JY, Honnorat J.

Neurology. 2014 Feb 18;82(7):556-63. doi: 10.1212/WNL.0000000000000126. Epub 2014 Jan 17.

PMID:
24443452
3.

Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.

Ong E, Viaccoz A, Ducray F, Pérol M, Cavillon G, Rogemond V, Honnorat J, Petiot P.

Eur J Neurol. 2013 Jul;20(7):e96-7. doi: 10.1111/ene.12164. No abstract available.

PMID:
23750840
4.

Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer.

Honnorat J, Didelot A, Karantoni E, Ville D, Ducray F, Lambert L, Deiva K, Garcia M, Pichit P, Cavillon G, Rogemond V, DeLattre JY, Tardieu M.

Neurology. 2013 Jun 11;80(24):2226-32. doi: 10.1212/WNL.0b013e318296e9c3. Epub 2013 May 8.

PMID:
23658383
5.

Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Marignier R, Bernard-Valnet R, Giraudon P, Collongues N, Papeix C, Zéphir H, Cavillon G, Rogemond V, Casey R, Frangoulis B, De Sèze J, Vukusic S, Honnorat J, Confavreux C; NOMADMUS Study Group.

Neurology. 2013 Jun 11;80(24):2194-200. doi: 10.1212/WNL.0b013e318296e917. Epub 2013 May 8.

PMID:
23658379
6.

Brain immunohistopathological study in a patient with anti-NMDAR encephalitis.

Camdessanché JP, Streichenberger N, Cavillon G, Rogemond V, Jousserand G, Honnorat J, Convers P, Antoine JC.

Eur J Neurol. 2011 Jun;18(6):929-31. doi: 10.1111/j.1468-1331.2010.03180.x. Epub 2010 Aug 16.

PMID:
20722705
7.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P.

Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.

PMID:
20688809
8.

Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?

Marignier R, Chenevier F, Rogemond V, Sillevis Smitt P, Renoux C, Cavillon G, Androdias G, Vukusic S, Graus F, Honnorat J, Confavreux C.

Arch Neurol. 2010 May;67(5):627-30. doi: 10.1001/archneurol.2010.51.

PMID:
20457964
9.

NMO-IgG and Devic's neuromyelitis optica: a French experience.

Marignier R, De Sèze J, Vukusic S, Durand-Dubief F, Zéphir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C.

Mult Scler. 2008 May;14(4):440-5. doi: 10.1177/1352458507084595. Epub 2008 Jan 21.

PMID:
18208892
10.

Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia.

Davoust N, Vuaillat C, Cavillon G, Domenget C, Hatterer E, Bernard A, Dumontel C, Jurdic P, Malcus C, Confavreux C, Belin MF, Nataf S.

FASEB J. 2006 Oct;20(12):2081-92.

PMID:
17012260
11.

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, Chereul E, Langlois JB, Dumontel C, Cavillon G, Confavreux C, Mazzorana M, Vico L, Belin MF, Vivier E, Tomasello E, Jurdic P.

Am J Pathol. 2005 Jan;166(1):275-86.

Supplemental Content

Loading ...
Support Center